Effects of Lactocaseibacillus paracasei subsp. paracasei NTU 101 on gut microbiota: a randomized, double‐blind, placebo‐controlled clinical study
Journal of the Science of Food and Agriculture · 2024
DOI: 10.1002/jsfa.13772 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the Science of Food and Agriculture, 2024. Verfasst von Tzu-Hsing Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, National Taitung University, Taitung, Taiwan. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Probiotics, Feces, Lacticaseibacillus paracasei. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Lactocaseibacillus paracasei subsp. paracasei NTU 101 (NTU101) is a well‐known commercial probiotic with multiple health beneficial effects. In this study, the gut microbiota modulation effect of an NTU 101 product, Vigiis 101‐LAB, on healthy human was investigated in a randomized, double‐blind, placebo‐controlled human trial. RESULTS Vigiis 101‐LAB significantly modulated human gut microbiota at fourth and sixth weeks of trial (anosim analysis, P = 0.001). It also significantly improved peristalsis ( P = 0.003) and shortened defecation interval of subjects. The shift of gut microbiota is significantly fit with defecation interval ( P = 0.009) and stool shape ( P = 0.001) of subjects. CONCLUSION Our results suggest that Vigiis 101‐LAB promotes human intestinal health with improvement of peristalsis and fecal quality. The gut modulation effects of Vigiis 101‐LAB subsequently raised the abundance of vitamin B7, vitamin K, pyrimidine and purine biosynthesis pathways. Vigiis 101‐LAB may promote peristalsis via purinergic pathway and possibly conferring prophylactic benefits against irritable bowel syndrome with constipation. © 2024 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Science, National Taitung University, Taitung, Taiwan.
- SunWay Biotech Ltd., Taipei, Taiwan.
ORCID-Profile: Chih-Hui Lin
Zitieren
APA
Lin, T. H., Shih, T. W., & Lin, C. H. (2024). Effects of Lactocaseibacillus paracasei subsp. paracasei NTU 101 on gut microbiota: a randomized, double‐blind, placebo‐controlled clinical study. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.13772
Vancouver
Lin TH, Shih TW, Lin CH. Effects of Lactocaseibacillus paracasei subsp. paracasei NTU 101 on gut microbiota: a randomized, double‐blind, placebo‐controlled clinical study. Journal of the Science of Food and Agriculture. 2024. doi:10.1002/jsfa.13772
BibTeX
@article{Lin2024,
author = {Lin, Tzu-Hsing and Shih, Tsung-Wei and Lin, Chih-Hui},
title = {Effects of Lactocaseibacillus paracasei subsp. paracasei NTU 101 on gut microbiota: a randomized, double‐blind, placebo‐controlled clinical study},
journal = {Journal of the Science of Food and Agriculture},
year = {2024},
doi = {10.1002/jsfa.13772}
}
EUVIMED